Mutations in other genes such as ASXL1, EZH2, SRSF2, and SH2B3 were also more frequently observed in primary samples of patients who had experienced transformation of MPN into BP (1, 2, 7–13), suggesting a role for these events in LT. The gene discussed is SRSF2; the disease is myeloproliferative neoplasm.